Skip to main content
SpringerLink
Log in

Psoriasis and psoriasiform eruptions associated with propranolol — the role of an immunological mechanism

  • Short Communications
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Amos HE, Bridgen WD, McKerron RA (1975) Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. BMJ 1:598–600

    Google Scholar 

  2. Anderson TF, Voorhees JJ (1986) Psoriasis. In: Thiers BH, Dobson RL (eds) Pathogenesis of skin disease, 1st edn. Churchill-Livingstone, New York, pp 67–84

    Google Scholar 

  3. Arntzen N, Kavli G, Volden G (1984) Psoriasis provoked by Β-blocking agents. Acta Derm Venereol (Stockh) 64:346–348

    Google Scholar 

  4. David JR, Al-Askaris S, Lawrence HS, Thomas L (1964) Delayed hypersensitivity in vitro. I: The specificity of inhibitor cell migration by antigens. J Immunol 92:264–273

    Google Scholar 

  5. Felix RH, Ive FA, Dahl MGC (1974) Cutaneous and ocular reactions to practolol. BMJ 4:321–324

    Google Scholar 

  6. Halevy S, Feuerman EJ (1979) Psoriasiform eruption induced by propranolol. Cutis 24:95–98

    Google Scholar 

  7. Halevy S, Grunwald MH, Sandbank M, Buimovice B, Joshua H, Livni E (1990) Macrophage migration inhibition factor (MIF) in drug eruption. Arch Dermatol 126:48–51

    Google Scholar 

  8. Jensen HA, Mikkelsen HI, Wadskov S, Sondergaard J (1976) Cutaneous reactions to propranolol (Inderal). Acta Med Scand 199:363–367

    Google Scholar 

  9. Livni E, Halevy S, Stahl B, Joshua H (1987) The appearance of macrophage migration inhibition factor in drug reactions. J Allergy Clin Immunol 80:843–849

    Google Scholar 

  10. Raftery EB, Denman AM (1973) Systemic lupus erythematosus syndrome induced by practolol. BMJ 2:452–455

    Google Scholar 

  11. Sondergaard J, Wadskov S, Jensen HA, Mikkelsen HI (1976) Aggravation of psoriasis and occurrence of psoriasiform eruptions induced by practolol (Eraldin). Acta Derm Venereol (Stockh) 56:239–243

    Google Scholar 

  12. Staughton R, Sutton R, Farrel M (1980) Β-Blockers, autoimmunity and rashes. Lancet II:581

    Google Scholar 

  13. Van Joost T, Sillevis Smitt JH (1981) Skin reactions to propranolol and cross sensitivity to Β-adrenoreceptor blocking agents. Arch Dermatol 117:600–601

    Google Scholar 

  14. Wolf R, Livni E, Joshua H (1984) Concurrent cell-mediated immunity and immediate hypersensitivity in animal model. Ann Allergy 52:300–302

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Soroka Medical Center, P.O. Box 151, 84101, Beer-Sheva, Israel

    S. Halevy

  2. The Faculty of Health Sciences, Ben-Gurion University of the Negev, 84101, Beer-Sheva, Israel

    S. Halevy

  3. The Clinical Laboratory, Beilinson Medical Center, Petah Tiqva, Israel

    E. Livni

Authors
  1. S. Halevy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Livni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halevy, S., Livni, E. Psoriasis and psoriasiform eruptions associated with propranolol — the role of an immunological mechanism. Arch Dermatol Res 283, 472–473 (1991). https://doi.org/10.1007/BF00371785

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00371785

Key words

Search

Navigation